The abstract is read at the publisher; the summary is JClub's.
All tested Gram-positive human pathobionts were susceptible to plasmenyl-LPC (pLPC)(18:0), while Gram-negative Escherichia coli and Pseudomonas aeruginosa were not, at physiologically relevant concentrations.
- Why it matters: Host-derived lysophosphatidylcholine species shape innate immunity, yet pLPC’s antibacterial potential and how different bacteria adapt to LPC-like stress remained unclear.
- What they did: They compared growth inhibition by LPC(18:0) versus pLPC(18:0) across multiple human pathobionts, then tested whether LPC-containing medium pretreated with E. faecalis could rescue S. agalactiae.
- The result: pLPC showed robust antimicrobial activity, LPC killed S. aureus and S. agalactiae but not completely enterococci, and spontaneous LPC-resistant S. aureus emerged with walK, fabF, and farR point mutations linked to increased farE efflux pump expression.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.